Baroness Whitaker Alert Sample


Alert Sample

View the Parallel Parliament page for Baroness Whitaker

Information between 24th April 2026 - 13th July 2026

Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.


Division Votes
27 Apr 2026 - English Devolution and Community Empowerment Bill - View Vote Context
Baroness Whitaker voted No - in line with the party majority and against the House
One of 136 Labour No votes vs 1 Labour Aye votes
Tally: Ayes - 199 Noes - 144
27 Apr 2026 - English Devolution and Community Empowerment Bill - View Vote Context
Baroness Whitaker voted No - in line with the party majority and in line with the House
One of 133 Labour No votes vs 0 Labour Aye votes
Tally: Ayes - 58 Noes - 138
27 Apr 2026 - English Devolution and Community Empowerment Bill - View Vote Context
Baroness Whitaker voted No - in line with the party majority and against the House
One of 139 Labour No votes vs 1 Labour Aye votes
Tally: Ayes - 210 Noes - 145
27 Apr 2026 - English Devolution and Community Empowerment Bill - View Vote Context
Baroness Whitaker voted No - in line with the party majority and against the House
One of 139 Labour No votes vs 1 Labour Aye votes
Tally: Ayes - 217 Noes - 145
27 Apr 2026 - Children’s Wellbeing and Schools Bill - View Vote Context
Baroness Whitaker voted No - in line with the party majority and against the House
One of 153 Labour No votes vs 5 Labour Aye votes
Tally: Ayes - 316 Noes - 165
27 Apr 2026 - Pension Schemes Bill - View Vote Context
Baroness Whitaker voted No - in line with the party majority and against the House
One of 125 Labour No votes vs 1 Labour Aye votes
Tally: Ayes - 197 Noes - 129
28 Apr 2026 - Children’s Wellbeing and Schools Bill - View Vote Context
Baroness Whitaker voted No - in line with the party majority and in line with the House
One of 160 Labour No votes vs 0 Labour Aye votes
Tally: Ayes - 91 Noes - 181
8 Jul 2026 - Steel Industry (Nationalisation) Bill - View Vote Context
Baroness Whitaker voted No - in line with the party majority and in line with the House
One of 139 Labour No votes vs 1 Labour Aye votes
Tally: Ayes - 95 Noes - 202


Speeches
Baroness Whitaker speeches from: Railways Bill
Baroness Whitaker contributed 1 speech (455 words)
2nd reading
Tuesday 7th July 2026 - Lords Chamber
Department for Transport
Baroness Whitaker speeches from: Livestock Grazing on Dartmoor National Park
Baroness Whitaker contributed 1 speech (49 words)
Thursday 18th June 2026 - Lords Chamber
Baroness Whitaker speeches from: Online Hate Speech
Baroness Whitaker contributed 1 speech (111 words)
Tuesday 16th June 2026 - Lords Chamber
Department for Business and Trade
Baroness Whitaker speeches from: King’s Speech
Baroness Whitaker contributed 1 speech (604 words)
Thursday 21st May 2026 - Lords Chamber
Ministry of Defence
Baroness Whitaker speeches from: Chemicals (Health and Safety) (Amendment, Consequential and Transitional Provision) Regulations 2026
Baroness Whitaker contributed 1 speech (60 words)
Monday 27th April 2026 - Lords Chamber
Department for Work and Pensions


Written Answers
Aphasia: Speech and Language Therapy
Asked by: Baroness Whitaker (Labour - Life peer)
Wednesday 29th April 2026

Question to the Department of Health and Social Care:

To ask His Majesty's Government what steps they are taking to ensure that people with Primary Progressive Aphasia can access speech and language therapy through Specialised Cognitive Neurology Services in all specialised neurology centres.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

Provision of dementia health care services is the responsibility of local integrated care boards (ICBs). NHS England would expect ICBs to commission services based on local population needs, taking account of the National Institute for Health and Care Excellence guidelines.

The Government is committed to improving care for everyone with dementia, including those with Primary Progressive Aphasia, which is why we have funded the work of the Dementia 100: Assessment Tool Pathway programme, which brings together multiple resources into a single, consolidated tool. This will help simplify best practice for busy system leaders and help create communities and services where the best possible care and support is available to those with dementia.

A number of experts, including those with expertise in speech and language therapy and dementia care, provided independent, desktop analysis of the tool and this invaluable feedback was integrated into the tool. The D100: Pathway Assessment Tool is available on the Royal College of Psychiatrists’ website.

Travellers: Health
Asked by: Baroness Whitaker (Labour - Life peer)
Wednesday 29th April 2026

Question to the Department of Health and Social Care:

To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 12 March (HL13897), what are the health disparities of Gypsy, Traveller and Roma ethnic groups in the areas in that Answer, in particular (1) maternal mortality outcomes, (2) mental health provision, (3) cancer outcomes, and (4) cardiovascular disease; and what action they are taking to reduce those disparities.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

It is a priority for the Government to increase the amount of time people spend in good health and prevent premature deaths. Our 10-Year Health Plan for England sets out a reimagined service designed to tackle inequalities in both access and outcomes, including our ambitious commitment to halve the healthy life expectancy gap between the richest and poorest regions.

NHS England has launched a Maternity and Neonatal Equalities dashboard that brings together key information to address health inequalities in maternity and neonatal care services from a range of data sources, with breakdowns by ethnicity and deprivation to make health inequalities visible, measurable, and actionable in maternity and neonatal services.

NHS England is implementing a new anti-discrimination programme, which aims to ensure all service users and their families will receive care free from discrimination and racism, and all staff will experience a work environment free from discrimination and racism. All trusts are expected to have completed the programme by 2027.

We have legislated to modernise the Mental Health Act to strengthen choice, autonomy and rights, and ensure people are treated with dignity and respect. The Government is also committed to delivering the cross-sector Suicide Prevention Strategy for England (2023 to 2028), including its ambition to improve evidence and better understand national trends and suicide rates in particular groups, including people who are Gypsy, Roma or Travellers.

The Government and NHS England have announced a three-year Neighbourhood Early Diagnosis Fund as part of £200 million investment for Cancer Alliances to tackle inequalities in screening and early diagnosis in deprived and underserved areas. Core20PLUS5 also includes early cancer diagnosis as a priority area for accelerated improvement.

The Department recognises inequalities exist across the cardiovascular disease (CVD) pathway. The Department and NHS England are working together to develop a CVD Modern Service Framework which will support, evidence-led consistent, high quality and equitable care.

Aphasia: Speech and Language Therapy
Asked by: Baroness Whitaker (Labour - Life peer)
Thursday 21st May 2026

Question to the Department of Health and Social Care:

To ask His Majesty's Government what steps they are taking to ensure that people with primary progressive aphasia can access speech and language therapy through specialised cognitive neurology services in all specialised neurology centres.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The provision of dementia health care services is the responsibility of local integrated care boards (ICBs). We expect ICBs to commission services based on local population needs, taking account of National Institute for Health and Care Excellence guidelines.

The Government is committed to improving care for everyone with dementia, including those with Primary Progressive Aphasia, which is why we have funded the work of the Dementia 100: Assessment Tool Pathway programme, which brings together multiple resources into a single, consolidated tool. This will help simplify best practice for busy system leaders and help create communities and services where the best possible care and support is available to those with dementia.

A number of experts, including those with expertise in speech and language therapy and dementia care, provided independent, desktop analysis of the tool and this invaluable feedback was integrated into the tool. The D100: Pathway Assessment Tool can be found on the Royal College of Psychiatrists’ website.

Travellers: Caravan Sites
Asked by: Baroness Whitaker (Labour - Life peer)
Monday 22nd June 2026

Question to the HM Treasury:

To ask His Majesty's Government what assessment they have made of the report by Friends, Families and Travellers They just refuse: Insurance companies failing to provide cover for Gypsy and Traveller site residents published on 26 May; and what steps are they taking to (1) address insurance access gaps for residents in Gypsy and Traveller sites through the Financial Inclusion Strategy,  and (2) engage with Gypsy and traveller communities to resolve issues relating to access to insurance.

Answered by Lord Livermore

The Government recognises the important role of insurance products in building financial resilience of consumers and giving households the ability to weather financial shocks.

This is why promoting financial resilience through insurance is a key focus in the Government’s Financial Inclusion Strategy. The Strategy was published last year and sets out a range of ambitious measures for industry and the Government to improve financial inclusion and resilience for underserved groups across the UK. This includes interventions to support the uptake of contents insurance among social renters, and better support individuals to find the right cover through signposting initiatives.

The Government engaged with a range of consumer representatives, including people with lived experience, throughout the development of the Strategy to ensure it is informed by a wide range of experience and perspectives. The Government is committed to continuing to engage closely with a range of organisations to ensure the Strategy represents a diverse range of consumer needs.

Individual insurers may take a different view of the relevant factors in determining whether they will offer insurance and at what price. Consumers may wish to contact the British Insurance Brokers’ Association (BIBA), who can offer guidance on how to look across the insurance market for the best deals and may be able to provide names of specialist brokers.

Special Educational Needs
Asked by: Baroness Whitaker (Labour - Life peer)
Wednesday 1st July 2026

Question to the Department for Education:

To ask His Majesty's Government what plans they have to introduce a statutory requirement for local authorities and Integrated Care Boards to jointly commission services across all layers of SEND support.

Answered by Baroness Smith of Malvern - Minister of State (Department for Work and Pensions)

Under section 26 of the Children and Families Act 2014, local authorities and Integrated Care Boards have an existing duty to jointly commission the arrangements for the education, health and care of children and young people with Special educational needs and disability (SEND) in the local area.

In the SEND consultation, the government asked how to ensure the most effective use of SEND local partnerships through the SEND reforms. Partnership working includes the existing joint commissioning arrangements between local authorities and Integrated Care Boards.

The consultation has now closed. The department is carefully reviewing and taking into account all responses submitted to the consultation alongside feedback from over 200 engagement events we held over 12 weeks and will set out our response in due course.

Neurology
Asked by: Baroness Whitaker (Labour - Life peer)
Thursday 2nd July 2026

Question to the Department of Health and Social Care:

To ask His Majesty's Government whether NHS England's Specialised Neurology Services (Adults) Specification will be implemented by all specialised neurology centres in England; and what steps they are taking to monitor compliance with those requirements for patients with Primary Progressive Aphasia.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The adult neurology service specification, published by NHS England, sets out the standards expected of specialised neurology services commissioned across England, including multidisciplinary care, timely access to diagnostics, and coordinated pathways for people with complex neurological conditions such as primary progressive aphasia. Specialised neurology services are commissioned against these national specifications, and providers are expected to deliver care in line with these requirements.

NHS England requires all commissioned specialised neurology centres to have regard to the service specification and to embed its standards within clinical practice. Implementation is supported through contractual arrangements and service development discussions between NHS England and providers, recognising that local service configuration and patient need may shape the way in which requirements are delivered in practice.

Compliance with service specifications is monitored through a structured combination of contractual obligations, routine data reporting, and external regulatory oversight. In addition, national improvement programmes, such as Getting It Right First Time, support the reduction of unwarranted variation and promote adherence to best practice, including for people with rarer neurological conditions such as primary progressive aphasia.

Together, these arrangements help to ensure that patients receive high-quality, evidence-based care in line with nationally defined standards, while allowing services to be delivered in a way that reflects local clinical pathways and patient needs.

Speech and Language Therapy
Asked by: Baroness Whitaker (Labour - Life peer)
Thursday 2nd July 2026

Question to the Department of Health and Social Care:

To ask His Majesty's Government what plans they have to embed speech and language therapists in neighbourhood health teams.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

Neighbourhood health underpins delivery of the 10-Year Health Plan. It will bring together integrated neighbourhood teams of professionals and partners closer to people’s home, to work together to support people and places to improve their health and wellbeing. We will publish a 10 Year Workforce Plan, which will put the National Health Service workforce on a sustainable footing so it can deliver the service model set out in the 10-Year Health Plan.

We expect the design and delivery of neighbourhood health to be locally led, including for integrated neighbourhood teams (INTs). However, INTs can include allied health professionals like speech and language therapists if this reflects the specific needs of the local population.

Travellers: Caravan Sites
Asked by: Baroness Whitaker (Labour - Life peer)
Tuesday 7th July 2026

Question to the HM Treasury:

To ask His Majesty's Government, further to the Written Answer by Lord Livermore on 22 June (HL765), what engagement they have had with Gypsy and Traveller communities in respect of insurance for people who live permanently on caravan sites.

Answered by Lord Livermore

The Government understands the importance of insurance in building the financial resilience of consumers and protecting them when things go wrong. The Government engages with a wide range of interest groups as part of its work to ensure insurance markets work well for consumers. The Government exchanged correspondence with Friends, Families and Travellers on the issue of access to insurance in late 2025.

While insurers make commercial decisions on whether to offer cover, and at what price, they must comply with relevant legislation and regulatory rules. The Equality Act 2010 prohibits discrimination based on protected characteristics, such as race. The Financial Conduct Authority (FCA) also requires firms to treat customers fairly under its rules and, where necessary, has robust powers to take action against firms that do not comply with its rules.




Baroness Whitaker mentioned

Live Transcript

Note: Cited speaker in live transcript data may not always be accurate. Check video link to confirm.

23 Jun 2026, 11:01 a.m. - Environment and Climate Change Committee
"Um, so Baroness Whitaker, over to you. "
Speaker 1 - View Video - View Transcript
7 Jul 2026, 7:05 p.m. - House of Lords
"to follow Baroness Whitaker, and I would like to associate myself with the chorus of praise for my noble friend Lord Wilson of Dinton, who "
Baroness Whitaker (Labour) - View Video - View Transcript
7 Jul 2026, 7:05 p.m. - House of Lords
"delighted to commend it here. >> My Lords, it's always a pleasure to follow Baroness Whitaker, and I "
Baroness Whitaker (Labour) - View Video - View Transcript
7 Jul 2026, 8:19 p.m. - House of Lords
"Jones of Moulsecoomb and Baroness Whitaker. But for example, in the world of freight ports and freight "
Baroness Pidgeon (Liberal Democrat) - View Video - View Transcript
7 Jul 2026, 8:46 p.m. - House of Lords
"is, is welcome, as the noble Baroness Whitaker said, it will "
Lord Hendy of Richmond Hill (Labour) - View Video - View Transcript
7 Jul 2026, 8:59 p.m. - House of Lords
"travel, more travel by, by, frankly, half the population. The noble Baroness Whitaker referred to staff "
Lord Hendy of Richmond Hill (Labour) - View Video - View Transcript


Select Committee Documents
Tuesday 23rd June 2026
Formal Minutes - Formal minutes for 17 June 2026

Environment and Climate Change Committee

Found: Ewelme Lord Krebs Lord Lennie Baroness McIntosh of Pickering Lord Rooker Lord Trees Baroness Whitaker

Tuesday 23rd June 2026
Oral Evidence - Defra, Veterinary Medicines Directorate, Veterinary Medicines Directorate, and Environment Agency

Pet Parasite Medication - Environment and Climate Change Committee

Found: Baroness Whitaker: Is this human health not from the parasites, though?

Wednesday 17th June 2026
Formal Minutes - Formal minutes for 10 June 2026

Environment and Climate Change Committee

Found: Krebs Lord Lennie Baroness McIntosh of Pickering Lord Rooker Earl Russell Lord Trees Baroness Whitaker

Wednesday 17th June 2026
Oral Evidence - National Office of Animal Health (NOAH), European Scientific Counsel Companion Animal Parasites (ESCCAP), and Elanco

Pet Parasite Medication - Environment and Climate Change Committee

Found: Baroness Whitaker: It sounds like an interesting area for further research.

Wednesday 10th June 2026
Formal Minutes - Formal minutes for 3 June 2026

Environment and Climate Change Committee

Found: Ewelme Lord Krebs Lord Lennie Baroness McIntosh of Pickering Lord Rooker Lord Trees Baroness Whitaker

Wednesday 10th June 2026
Oral Evidence - British Veterinary Association (BVA), Grantham Institute, and Chipping Norton Veterinary Hospital

Pet Parasite Medication - Environment and Climate Change Committee

Found: Krebs; Lord Lennie; Baroness McIntosh of Pickering; Lord Rooker; Earl Russell; Lord Trees; Baroness Whitaker

Thursday 4th June 2026
Declarations of interest - Declarations of interest - June 2026

Environment and Climate Change Committee

Found: Baroness Whitaker No relevant interests declared

Thursday 4th June 2026
Formal Minutes - Formal minutes for 20 May 2026

Environment and Climate Change Committee

Found: Krebs Lord Lennie Baroness McIntosh of Pickering Lord Rooker Earl Russell Lord Trees Baroness Whitaker

Wednesday 3rd June 2026
Oral Evidence - University of York, Matthew Shardlow, and Imperial College London

Pet Parasite Medication - Environment and Climate Change Committee

Found: Ewelme; Lord Krebs; Lord Lennie; Baroness McIntosh of Pickering; Lord Rooker; Lord Trees; Baroness Whitaker



Deposited Papers
Tuesday 30th June 2026
Ministry of Defence
Source Page: Letter dated 26/06/2026 from Lord Coaker to Baroness Chapman regarding issues raised in the King's speech debate on foreign and defence policy. 15p.
Document: 20260626_-_Joint_Kings_Speech_Debate_Letter.pdf (PDF)

Found: International anti-corruption and illicit finance Baroness Whitaker raised the importance of sustained




Baroness Whitaker - Select Committee Information

Calendar
Wednesday 20th May 2026 10 a.m.
Environment and Climate Change Committee - Private Meeting
View calendar - Add to calendar
Wednesday 10th June 2026 10 a.m.
Environment and Climate Change Committee - Oral evidence
Subject: Pet Parasite Medication
At 10:00am: Oral evidence
Dr Elizabeth Mullineaux - Senior Vice President at British Veterinary Association (BVA)
Dr Rose Perkins - Veterinary Surgeon and Visiting Fellow at Grantham Institute
Dr Martin Whitehead - Senior Veterinary Surgeon at Chipping Norton Veterinary Hospital
View calendar - Add to calendar
Wednesday 17th June 2026 10 a.m.
Environment and Climate Change Committee - Oral evidence
Subject: Pet Parasite Medication
At 10:00am: Oral evidence
Dr Donal Murphy - Deputy CEO and Head of International and Regulatory Affairs at National Office of Animal Health (NOAH)
Dr Ian Wright - Chairman and Director at European Scientific Counsel Companion Animal Parasites (ESCCAP)
Dr Jacqui Skelly MRCVS - Head of Veterinary Technical Services at Elanco
View calendar - Add to calendar
Wednesday 3rd June 2026 10 a.m.
Environment and Climate Change Committee - Oral evidence
Subject: Pet Parasite Medication
At 10:00am: Oral evidence
Professor Alistair Boxall - Professor in Environmental Science at University of York
Matthew Shardlow - Ecological consultant
Professor Guy Woodward - Professor of Ecology at Imperial College London
View calendar - Add to calendar
Tuesday 23rd June 2026 10 a.m.
Environment and Climate Change Committee - Oral evidence
Subject: Pet Parasite Medication
At 10:00am: Oral evidence
The Baroness Hayman of Ullock - Parliamentary Under-Secretary of State at Defra
Abigail Seager - Director at Veterinary Medicines Directorate
Francine Fernandez - Senior Environmental Safety Assessor, Pharmaceuticals Team at Veterinary Medicines Directorate
Dr Robert Bradburne - Chief Scientist at Environment Agency
View calendar - Add to calendar
Wednesday 15th July 2026 10 a.m.
Environment and Climate Change Committee - Private Meeting
View calendar - Add to calendar
Wednesday 2nd September 2026 10 a.m.
Environment and Climate Change Committee - Private Meeting
View calendar - Add to calendar
Wednesday 22nd July 2026 10 a.m.
Environment and Climate Change Committee - Private Meeting
View calendar - Add to calendar


Select Committee Documents
Monday 27th April 2026
Correspondence - Letter from DESNZ on Climate Change Act 2008 (International Aviation and International Shipping) Regulations 2026 17.04.2026

Environment and Climate Change Committee
Monday 27th April 2026
Correspondence - Letter from the Environment Agency on waste crime letter dated 24 March with corrected data 22.04.2026

Environment and Climate Change Committee
Wednesday 13th May 2026
Correspondence - Letter to the Environment Agency on waste crime letter dated 24 March with corrected data 13.05.2026

Environment and Climate Change Committee
Tuesday 19th May 2026
Correspondence - Letter to DESNZ on Climate Change Act 2008 (International Aviation and International Shipping) Regulations 2026 15.05.2026

Environment and Climate Change Committee
Wednesday 20th May 2026
Correspondence - Letter from DESNZ on Prax Linsey Oil Refinery 29.04.2026

Environment and Climate Change Committee
Wednesday 10th June 2026
Written Evidence - Johnson's Veterinary Products
PPM0016 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Wednesday 10th June 2026
Written Evidence - Veterinary Medicines Directorate, DEFRA
PPM0015 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Wednesday 10th June 2026
Correspondence - Letter from DESNZ Secretary of State on Setting the Seventh Carbon Budget 02.06.2026

Environment and Climate Change Committee
Wednesday 10th June 2026
Formal Minutes - Formal minutes for 3 June 2026

Environment and Climate Change Committee
Wednesday 10th June 2026
Correspondence - Letter from Defra on Farming Profitability Review 01.06.2026

Environment and Climate Change Committee
Wednesday 17th June 2026
Written Evidence - Buglife
PPM0017 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Wednesday 17th June 2026
Written Evidence - Royal Society of Chemistry (RSC)
PPM0019 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Wednesday 17th June 2026
Written Evidence - Canine & Feline Sector Group
PPM0018 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Wednesday 17th June 2026
Correspondence - Letter to Defra on future Sanitary and Phytosanitary Agreement with the EU 17.06.2026

Environment and Climate Change Committee
Wednesday 17th June 2026
Formal Minutes - Formal minutes for 10 June 2026

Environment and Climate Change Committee
Thursday 4th June 2026
Correspondence - Letter from Defra on future Sanitary and Phytosanitary Agreement with the EU 28.05.2026

Environment and Climate Change Committee
Thursday 4th June 2026
Correspondence - Letter from the Environment Agency on high priority waste sites list 22.05.2026

Environment and Climate Change Committee
Thursday 4th June 2026
Correspondence - Letter to the Environment Agency on 25 March oral evidence session follow-up on waste crime 04.06.2026

Environment and Climate Change Committee
Thursday 4th June 2026
Correspondence - Letter from the Environment Agency on 25 March oral evidence session follow-up on waste crime 19.05.2026

Environment and Climate Change Committee
Thursday 4th June 2026
Formal Minutes - Formal minutes for 20 May 2026

Environment and Climate Change Committee
Thursday 4th June 2026
Declarations of interest - Declarations of interest - June 2026

Environment and Climate Change Committee
Wednesday 3rd June 2026
Written Evidence - National Office of Animal Health (NOAH)
PPM0013 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Wednesday 3rd June 2026
Written Evidence - SongBird Survival
PPM0014 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Wednesday 3rd June 2026
Oral Evidence - University of York, Matthew Shardlow, and Imperial College London

Pet Parasite Medication - Environment and Climate Change Committee
Wednesday 10th June 2026
Oral Evidence - British Veterinary Association (BVA), Grantham Institute, and Chipping Norton Veterinary Hospital

Pet Parasite Medication - Environment and Climate Change Committee
Tuesday 16th June 2026
Correspondence - Letter to DESNZ Secretary of State on Setting the Seventh Carbon Budget 16.06.2026

Environment and Climate Change Committee
Tuesday 16th June 2026
Correspondence - Letter to Defra on Farming Profitability Review 16.06.2026

Environment and Climate Change Committee
Tuesday 23rd June 2026
Written Evidence - UK Centre for Ecology & Hydrology (UKCEH)
PPM0023 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Tuesday 23rd June 2026
Written Evidence - Yorkshire Water
PPM0024 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Tuesday 23rd June 2026
Written Evidence - Johnson's Veterinary Products
PPM0021 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Tuesday 23rd June 2026
Written Evidence - Water UK
PPM0022 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Wednesday 17th June 2026
Oral Evidence - National Office of Animal Health (NOAH), European Scientific Counsel Companion Animal Parasites (ESCCAP), and Elanco

Pet Parasite Medication - Environment and Climate Change Committee
Tuesday 23rd June 2026
Written Evidence - Wales Environment Link
PPM0020 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Tuesday 23rd June 2026
Formal Minutes - Formal minutes for 17 June 2026

Environment and Climate Change Committee
Tuesday 23rd June 2026
Oral Evidence - Defra, Veterinary Medicines Directorate, Veterinary Medicines Directorate, and Environment Agency

Pet Parasite Medication - Environment and Climate Change Committee
Wednesday 3rd June 2026
Written Evidence - Johnson's Veterinary Products
PPM0012 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Wednesday 3rd June 2026
Written Evidence - Pet Industry Federation
PPM0003 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Wednesday 3rd June 2026
Written Evidence - Cardiff University
PPM0001 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Wednesday 3rd June 2026
Written Evidence - Dŵr Cymru Welsh Water
PPM0002 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Wednesday 3rd June 2026
Written Evidence - Cats Protection
PPM0007 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Wednesday 3rd June 2026
Written Evidence - RSPCA
PPM0004 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Wednesday 3rd June 2026
Written Evidence - The Wildlife Trusts
PPM0008 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Wednesday 3rd June 2026
Written Evidence - Royal Kennel Club
PPM0005 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Wednesday 3rd June 2026
Written Evidence - Producing Rational Evidence for Parasiticide Prescription
PPM0006 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Wednesday 3rd June 2026
Written Evidence - Environment Agency
PPM0011 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Wednesday 3rd June 2026
Written Evidence - UK Water Industry Research
PPM0010 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Wednesday 3rd June 2026
Written Evidence - Association of Dog and Cat Homes
PPM0009 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Monday 6th July 2026
Written Evidence - Grantham Institute
PPM0035 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Monday 6th July 2026
Written Evidence - GeoSpatial Analytics
PPM0036 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Monday 6th July 2026
Written Evidence - Matthew Shardlow
PPM0034 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Monday 6th July 2026
Written Evidence - The Responsible Use of Medicines Alliance – Companion Animal and Equine (RUMA CA&E)
PPM0033 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Monday 6th July 2026
Written Evidence - People's Dispensary for Sick Animals
PPM0028 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Monday 6th July 2026
Written Evidence - Grantham Institute, and Chipping Norton Veterinary Hospital
PPM0027 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Monday 6th July 2026
Written Evidence - Scottish Environment Protection Agency
PPM0025 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Monday 6th July 2026
Written Evidence - Anglian Water
PPM0026 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Monday 6th July 2026
Written Evidence - British Veterinary Association (BVA)
PPM0032 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Monday 6th July 2026
Written Evidence - European Scientific Counsel Companion Animal Parasites (ESCCAP)
PPM0029 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Monday 6th July 2026
Written Evidence - Natural Resources Wales / Cyfoeth Naturiol Cymru
PPM0031 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Monday 6th July 2026
Written Evidence - Imperial College London
PPM0030 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Monday 6th July 2026
Written Evidence - British Veterinary Association (BVA)
PPM0032 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Thursday 9th July 2026
Written Evidence - National Office of Animal Health (NOAH)
PPM0045 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Thursday 9th July 2026
Written Evidence - Veterinary Medicines Directorate (VMD), Environment Agency, and Defra
PPM0042 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Thursday 9th July 2026
Written Evidence - Elanco
PPM0041 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Thursday 9th July 2026
Written Evidence - Imperial College London, Imperial College London, and Grantham Institute
PPM0043 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Thursday 9th July 2026
Written Evidence - Grantham Institute
PPM0044 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Thursday 9th July 2026
Written Evidence - Grantham Institute
PPM0046 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Monday 6th July 2026
Written Evidence - Chipping Norton Veterinary Hospital
PPM0038 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Monday 6th July 2026
Written Evidence - The Exmoor Society
PPM0040 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Monday 6th July 2026
Written Evidence - Royal College of Veterinary Surgeons
PPM0039 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Monday 6th July 2026
Written Evidence - Veterinary Medicines Directorate (VMD)
PPM0037 - Pet Parasite Medication

Pet Parasite Medication - Environment and Climate Change Committee
Tuesday 14th July 2026
Government Response - Government response to Environment and Climate Change Committee report ‘Surviving drought: reclaim the rain’

Environment and Climate Change Committee
Wednesday 15th July 2026
Formal Minutes - Formal minutes for 23 June 2026

Environment and Climate Change Committee
Wednesday 15th July 2026
Declarations of interest - Declarations of interest - July 2026

Environment and Climate Change Committee
Wednesday 15th July 2026
Correspondence - Letter from Defra on future Sanitary and Phytosanitary Agreement with the EU 07.07.2026

Environment and Climate Change Committee
Wednesday 22nd July 2026
Formal Minutes - Formal minutes for 15 July 2026

Environment and Climate Change Committee


Select Committee Inquiry
24 Apr 2026
Pet Parasite Medication
Environment and Climate Change Committee (Select)
Not accepting submissions

This short inquiry will consider pet parasite medication (PPM), with a focus on treatments containing pesticides of concern such as fipronil and imidacloprid. The inquiry will seek to understand distribution pathways, and the impact of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and pet owners of alternative medications or application practices.

23 Jul 2026
Dunkelflaute and the risks of electricity intermittency
Environment and Climate Change Committee (Select)
Not accepting submissions

This inquiry will consider how the UK can maintain a secure, affordable and low-carbon electricity supply during ‘dunkelflaute’ events – periods of low wind and solar energy generation. This will include an assessment of current UK preparedness for dunkelflaute conditions, future plans, and policy and regulatory gaps.